Literature DB >> 17090642

Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.

Annemieke Roos1, Stephan J L Bakker, Thera P Links, Rijk O B Gans, Bruce H R Wolffenbuttel.   

Abstract

CONTEXT: Thyroid disease and the metabolic syndrome are both associated with cardiovascular disease.
OBJECTIVE: The aim of this study was to explore the hypothesis that thyroid function, in euthyroid subjects, is associated with components of the metabolic syndrome, including serum lipid concentrations and insulin resistance.
METHODS: A total of 2703 adult inhabitants of a middle-sized city in The Netherlands participated in this cross-sectional study. Subjects who were not euthyroid were excluded, as were subjects taking thyroid medication, medication for diabetes, and subjects for whom medication data were not available (n = 1122). Homeostasis model assessment for insulin resistance (HOMA-IR) (mU*mmol/liter2) was calculated as fasting insulin (mU/liter) times fasting glucose (mmol/liter) divided by 22.5. The metabolic syndrome was defined according to National Cholesterol Education Program's Adult Treatment Panel III criteria.
RESULTS: After adjustment for age and sex, free T4 (FT4) was significantly associated with total cholesterol [standardized beta (beta) = -0.059; P = 0.014], low-density lipoprotein cholesterol (beta = -0.068; P = 0.004), high-density lipoprotein cholesterol (beta = 0.100; P < 0.001), and triglycerides (beta = -0.102; P < 0.001). Both FT4 and TSH were significantly associated with HOMA-IR (beta = -0.133; P < 0.001 and beta = 0.055; P = 0.024, respectively). Median HOMA-IR increased from 1.42 in the highest tertile of FT4 to 1.66 in the lowest tertile of FT4. FT4 was significantly related to four of five components of the metabolic syndrome (abdominal obesity, triglycerides, high-density lipoprotein cholesterol, and blood pressure), independent of insulin resistance.
CONCLUSIONS: We have demonstrated an association between FT4 levels within the normal reference range and lipids, in accordance with the earlier observed association between (sub)clinical hypothyroidism and hyperlipidemia. Moreover, low normal FT4 levels were significantly associated with increased insulin resistance. These findings are consistent with an increased cardiovascular risk in subjects with low normal thyroid function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17090642     DOI: 10.1210/jc.2006-1718

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  143 in total

1.  The metabolic consequences of thyroxine replacement in adult hypopituitary patients.

Authors:  Helena Filipsson Nyström; Ulla Feldt-Rasmussen; Ione Kourides; Vera Popovic; Maria Koltowska-Häggström; Björn Jonsson; Gudmundur Johannsson
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

2.  Relationship between serum TSH level with obesity and NAFLD in euthyroid subjects.

Authors:  Jiaoyue Zhang; Hui Sun; Lulu Chen; Juan Zheng; Xiang Hu; Suxing Wang; Ting Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

3.  Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes.

Authors:  Vaia Lambadiari; Panayota Mitrou; Eirini Maratou; Athanasios E Raptis; Nikolaos Tountas; Sotirios A Raptis; George Dimitriadis
Journal:  Endocrine       Date:  2010-11-13       Impact factor: 3.633

4.  Thyroid function and lipid profile in euthyroid adults: the TCLSIH cohort study.

Authors:  Yeqing Gu; Ge Meng; Qing Zhang; Li Liu; Hongmei Wu; Shunming Zhang; Yawen Wang; Tingjing Zhang; Xuena Wang; Xingqi Cao; Huiping Li; Yunyun Liu; Xiaoyue Li; Xiaohe Wang; Shaomei Sun; Ming Zhou; Qiyu Jia; Kun Song; Kaijun Niu
Journal:  Endocrine       Date:  2020-04-24       Impact factor: 3.633

5.  Relationship of thyroid function with body mass index and insulin-resistance in euthyroid obese subjects.

Authors:  B Ambrosi; B Masserini; L Iorio; A Delnevo; A E Malavazos; L Morricone; L F Sburlati; E Orsi
Journal:  J Endocrinol Invest       Date:  2010-03-25       Impact factor: 4.256

6.  High-normal serum thyrotropin levels and increased glycemic variability in type 2 diabetic patients.

Authors:  Jian-Bin Su; Li-Hua Zhao; Xiu-Lin Zhang; Hong-Li Cai; Hai-Yan Huang; Feng Xu; Tong Chen; Xue-Qin Wang
Journal:  Endocrine       Date:  2018-04-12       Impact factor: 3.633

7.  Hormetic effect of triiodothyronine in metabolically healthy obese persons.

Authors:  Ji Eun Jun; Tae Hyuk Kim; Seung-Eun Lee; You-Bin Lee; Jae Hwan Jee; Ji Cheol Bae; Sang-Man Jin; Kyu Yeon Hur; Jae Hyeon Kim; Sun Wook Kim; Jae Hoon Chung; Yong-Ki Min; Moon-Kyu Lee
Journal:  Endocrine       Date:  2017-07-19       Impact factor: 3.633

Review 8.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

9.  Early signs of metabolic syndrome in pediatric central nervous system tumor survivors after high-dose chemotherapy and autologous stem-cell transplantation and radiation.

Authors:  Chantel Cacciotti; Muhammad Ali; Ute Bartels; Jonathan D Wasserman; Erilda Kapllani; Joerg Krueger; Eric Bouffet; Tal Schechter
Journal:  Childs Nerv Syst       Date:  2020-11-18       Impact factor: 1.475

10.  Elevated thyroid stimulating hormone levels are associated with metabolic syndrome in euthyroid young women.

Authors:  Jee-Young Oh; Yeon-Ah Sung; Hye Jin Lee
Journal:  Korean J Intern Med       Date:  2013-02-27       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.